戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 ( left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 is suggests that Myr might be a potential therapeutic agent for the treatment of DCM.
2 eam of WNT3A, where WNT3A antagonists could be novel agents for the treatment of metastasis and for skeletal complication
3 f fixed-dose combination of AM and PQP was comparable to AL for the treatment of uncomplicated P. falciparum malaria in p
4 ptides (AMPs) represent a promising therapeutic alternative for the treatment of antibiotic-resistant bacterial infection
5 kgroup provides recommendations for appropriate antibiotics for the treatment of sepsis.
6 ficacy of non-viral TUS-based hSef-b gene delivery approach for the treatment of prostate cancer tumors, and possibly oth
7 h STAT3 signaling inhibitor might be a therapeutic approach for the treatment of GBM.
8 urther development of this multifunctional vaccine approach for the treatment of synucleinopathies, such as Parkinson's d
9                   Purpose Bevacizumab regimens are approved for the treatment of recurrent glioblastoma in many countries
10 ozin is a sodium-glucose cotransporter-2 inhibitor approved for the treatment of type 2 diabetes.
11 rate SMA and demonstrates the promise of combinatorial ASOs for the treatment of neurogenetic disorders.
12 zobactam, ceftolozane-tazobactam, and ceftazidime-avibactam for the treatment of ESBL infections.
13  suggest that myricetin might be a potential drug candidate for the treatment of T2DM as a GLP-1R agonist.
14 r 2 (SGLT2) inhibitors are highly promising drug candidates for the treatment of Type 2 diabetes mellitus (T2DM).
15 1, an inhaled sialidase, is undergoing clinical development for the treatment of PIV in adults and children.
16         Cisplatin is the most commonly used anticancer drug for the treatment of testicular germ cell tumors (TGCTs).
17 ntrolled trial to document efficacy of a remyelinating drug for the treatment of chronic demyelinating injury in multiple
18 anol lavage followed by infusion of paclitaxel is effective for the treatment of mucinous pancreatic cysts.
19  a fixed combination of pepsin and amino acid hydrochloride for the treatment of patients with FD and also suggest good t
20 s, revealing a useful pharmacological point of intervention for the treatment of Huntington's disease, and potentially fo
21 nous enzyme replacement therapy was successfully introduced for the treatment of Gaucher's disease in the early 1990s.
22 t-term (</=60 min) infusion of antipseudomonal beta-lactams for the treatment of patients with sepsis was eligible.
23         Rituximab (RTX) has been the hallmark anti-CD20 mAb for the treatment of B cell neoplasms, including B cell chron
24 ications that relate to the increasing use of anti-IgE mAbs for the treatment of allergic disease.
25 livery has led to the development of novel nanotherapeutics for the treatment of various diseases including cancer.
26 cement (TMVR) has emerged as a potential therapeutic option for the treatment of severe MR.
27 ehensive assessment of GDF15 as a potential pharmacotherapy for the treatment of obesity.
28 (Ophtec B.V., Groningen, The Netherlands) iris-fixated pIOL for the treatment of myopia or astigmatism at the University
29  intramuscular benzathine penicillin G (BPG) is recommended for the treatment of early syphilis.
30  has proven to be a useful adjunct to breast reconstruction for the treatment of contour irregularities and volume defici
31 afety and efficacy of 12 weeks of sofosbuvir plus ribavirin for the treatment of acute HCV infection in participants with
32 romising chemotherapeutic strategy and its significant role for the treatment of drug-resistant TNBC.
33              Thymus transplantation is a promising strategy for the treatment of athymic complete DiGeorge syndrome (cDGS
34 ine receptor, a G-protein-coupled receptor that is a target for the treatment of Parkinson's disease.
35               Thus, SPHK2 might be an attractive new target for the treatment of fibrosis in chronic kidney disease.
36 udy suggests that Nav1.7 may provide a potential new target for the treatment of neuropathic pain, including chemotherapy
37       These results suggest that REV-ERB is a potent target for the treatment of DMD.
38  identifying this histone demethylase as a potential target for the treatment of anxiety and depression.
39                   This system represents a potential target for the treatment of metabolic diseases and has been extensiv
40 nin-opioid interactions and offers a new therapeutic target for the treatment of opioid use disorder.
41                  STS and 17beta-HSD1 are attractive targets for the treatment of estrogen-dependent diseases like endomet
42 ealed and this could serve as novel pharmacological targets for the treatment of mood disorders.
43 rt the use of transcatheter aortic valve replacement (TAVR) for the treatment of aortic stenosis in high- and intermediat
44 tarsudil 0.02% was found to be effective and well tolerated for the treatment of patients with ocular hypertension and op
45 psagargin, which is currently in late-stage clinical trials for the treatment of cancer, will also be accessible via this
46 lysine demethylase 1 inhibitor currently in clinical trials for the treatment of small cell lung carcinoma, was synthesiz
47             Compound 25 was advanced to first-in-man trials for the treatment of psychiatric conditions.
48 tendon or flexor digitorum longus tendon is frequently used for the treatment of posterior tibial tendon insufficiency or
49 rypsin (AAT; Prolastin-C), a serine protease inhibitor used for the treatment of AAT deficiency, inhibits IBMIR and cytok
50          The first evaluation of the general patient wishes for the treatment of DR confirmed the concept of SDM, which w

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。